2023 Highlights of ASH®

Highlights of ASH in the Mediterranean

February 17-18, 2023
Istanbul, Turkey

Join the world's leading hematology experts at Highlights of ASH in the Mediterranean, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical (non-malignant) hematology. ASH is pleased to conduct this year’s series as in-person meetings; there will not be a virtual meeting platform.

By attending Highlights of ASH in the Mediterranean, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Through participation in this meeting, you will be able to:

  • Recap stand-out abstracts from the most recent ASH annual meeting
  • Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field
  • Participate in interactive panel discussions and attend small group lunch sessions with the experts
  • Improve therapeutic and overall practice methods
  • Discover new treatments for patients 

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

Program Co-Host

ASH is proud to co-host this meeting with the Turkish Society of Hematology.

8:00 a.m. Registration and Exhibition Opens
8:45 a.m. Welcome and Introductions
9:00 a.m.

Myelodysplastic Syndromes
Olatoyosi Odenike, MD
University of Chicago
Chicago, IL

9:30 a.m.

Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia
Kristen Pettit, MD
University of Michigan
Ann Arbor, MI

10:00 a.m.

Panel Discussion
10:30 a.m. Coffee Break and Exhibition
11:00 a.m.

Disorders of Hemostasis
Alice Ma, MD
University of North Carolina
Chapel Hill, NC

11:30 a.m.

Sickle Cell Disease: Sickling and Other Hemoglobinopathies
Neil Zakai, MD
University of Vermont
Burlington, VT

12:00 p.m. Panel Discussion
12:30 p.m. Lunch with the Experts Session
1:45 p.m.

ITP/TTP, Immune Hemolysis, and aHUS
Sandhya Panch, MD
Seattle Cancer Care Alliance
Seattle, WA

2:15 p.m.

Transfusion Medicine and Apheresis
Vijay Bhoj, MD, PhD
University of Pennsylvania
Pennsylvania, Pennsylvania
2:45 p.m.

Venous Thromboembolism/Anticoagulation and Its Reversal
David Garcia, MD
University of Washington
Seattle, WA

3:15 p.m. Panel Discussion
3:45 p.m. Highlights of ASH Day 1 Program Adjournment
8:00 a.m. Registration and Exhibition
8:45 a.m. Welcome and Introductions
9:00 a.m.

Acquired Bone Marrow Failure Syndromes
Swapna Thota, MD 
University of Tennessee 
Memphis, TN   
9:30 a.m.

Hematopoietic Stem Cell Transplantation
Monzr M. Al Malki, MD
City of Hope
Duarte, CA

10:00 a.m. Panel Discussion
10:30 a.m. Coffee Break and Exhibition
11:00 a.m.

Chronic Lymphocytic Leukemia
Nitin Jain, MD
MD Anderson Cancer Center
Houston, TX

11:30 a.m.

Lymphoma
Ann LaCasce, MD
Dana-Farber Cancer Institute
Boston, MA

12:00 p.m. Panel Discussion
12:30 p.m. Lunch with the Experts Session
1:45 p.m.

Acute Myeloid Leukemia
Geoffrey Uy, MD
Washington University in St. Louis
St. Louis, MO
2:15 p.m.

Acute Lymphoblastic Leukemia
Emily Curran, MD
University of Cincinnati
Cincinnati, OH

2:45 p.m.

Myeloma & Plasma Cell Dyscrasia
Anita D'Souza, MD
Medical College of Wisconsin
Milwaukee, WI

3:15 p.m. Panel Discussion
3:45 p.m. Program Adjournment

Corporate Support

The American Society of Hematology would like to acknowledge the following companies for the educational grants provided in support of the 2023 Highlights of ASH in the Mediterranean:

  • AstraZeneca
  • Pfizer Inc.

Explore This Meeting